Novavax stock halted ahead of FDA advisory panel hearing on COVID vaccine

By Barron's
| June 07, 2022

Trading in Novavax shares was halted Tuesday in anticipation of an FDA advisory panel meeting in which regulators will make a ruling on whether to approve the company's COVID-19 vaccine.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...